RecruitingAccepts healthy volunteersEarly Phase 1
Mapping Auricular Vagus Nerve Circuitry
Massachusetts General Hospital · with National Institutes of Health (NIH) · NCT00200889
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- August 22, 2023
- Record last updated
- October 24, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will determine how noninvasive nerve stimulation affects human brain, stomach, and autonomic activity.
Being studied: active TEAS
Conditions: Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults 18-65
- Functional dyspepsia
Exclusion Criteria
- Any condition contraindicating an fMRI brain scan
Recruiting US locations
Massachusetts General Hospital
Boston, MA 02114
Site contact: Andy Bolender · abolender@mgh.harvard.edu
Study contacts (from the official record)
- Andy Bolender, B.A. · 617-643-4297 · abolender@mgh.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+